Table 1

Patient characteristics
ESRD patients, n = 1142
 Age, years 47.7 ± 13.5
 Sex: male, n (%) 662 (58.0)
 Primary disease:
 - glomerulonephritis, n (%) 242 (21.2)
 - autosomal dominant polycystic kidney disease, n (%) 155 (13.6)
 - pyelonephritis, n (%) 128 (11.2)
 - renal vascular disease, n (%) 110 (9.6)
 - IgA nephropathy, n (%) 89 (7.8)
 - diabetes types I and II, n (%) 47 (4.1)
 - other/uncertain etiology, n (%) 371 (32.5)
Kidney donors, n = 1184
 Age, years 44.5 ± 14.3
 Sex: male, n (%) 602 (50.8)
 Living donors, n (%) 282 (23.8)
 - from which related donors, n (%) 164 (58.2)
Matched donor-recipient pairs, n = 1066
 Recipient age, years 48.1 ± 13.5
 Recipient sex: male, n (%) 620 (58.2)
 Donor age, years 44.6 ± 14.3
 Donor sex: male, n (%) 540 (50.7)
 Living donors, n (%) 261 (24.5)
 Cold ischemia time, hours 17.4 [9.0-23.0]
 Total warm ischemia time, minutes 40.0 [34.0-51.0]
 Delayed graft function, n (%) 332 (31.1)
 Post-transplant follow-up duration, years 5.5 [3.0-8.7]
 Acute organ rejection episodes history, n (%) 368 (34.5)
 Death-censored graft failure, n (%) 172 (16.1)
 Death with a functioning graft, n (%) 182 (17.1)
Renal transplant recipients with urine available, n = 282
 Age, years 52.1 ± 12.3
 Sex: male, n (%) 152 (53.9)
 Urine collection time point, years after transplantation 4.2 [2.2-6.1]

Continuous normally distributed variables are presented as means ± SD, non-normally distributed – as medians [IQR].

Reznichenko et al.

Reznichenko et al. BMC Medical Genetics 2012 13:78   doi:10.1186/1471-2350-13-78

Open Data